JPH05502603A - 骨インプラント用生物活性ガラス状組成物、それから造られたフィラメント及び方法 - Google Patents
骨インプラント用生物活性ガラス状組成物、それから造られたフィラメント及び方法Info
- Publication number
- JPH05502603A JPH05502603A JP3503103A JP50310391A JPH05502603A JP H05502603 A JPH05502603 A JP H05502603A JP 3503103 A JP3503103 A JP 3503103A JP 50310391 A JP50310391 A JP 50310391A JP H05502603 A JPH05502603 A JP H05502603A
- Authority
- JP
- Japan
- Prior art keywords
- bone
- composition
- filament
- glassy
- produced
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims description 67
- 210000000988 bone and bone Anatomy 0.000 title claims description 44
- 239000007943 implant Substances 0.000 title claims description 13
- 230000000975 bioactive effect Effects 0.000 title claims description 10
- 238000000034 method Methods 0.000 title claims description 9
- 239000000835 fiber Substances 0.000 claims description 32
- 239000002245 particle Substances 0.000 claims description 24
- 239000000843 powder Substances 0.000 claims description 14
- 239000000463 material Substances 0.000 claims description 13
- 230000007547 defect Effects 0.000 claims description 10
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 6
- 229910052593 corundum Inorganic materials 0.000 claims description 5
- 229910001845 yogo sapphire Inorganic materials 0.000 claims description 5
- KKCBUQHMOMHUOY-UHFFFAOYSA-N Na2O Inorganic materials [O-2].[Na+].[Na+] KKCBUQHMOMHUOY-UHFFFAOYSA-N 0.000 claims description 3
- 238000005516 engineering process Methods 0.000 claims description 3
- 239000007921 spray Substances 0.000 claims description 3
- 229920000742 Cotton Polymers 0.000 claims description 2
- WUKWITHWXAAZEY-UHFFFAOYSA-L calcium difluoride Chemical compound [F-].[F-].[Ca+2] WUKWITHWXAAZEY-UHFFFAOYSA-L 0.000 claims description 2
- 229910001634 calcium fluoride Inorganic materials 0.000 claims description 2
- 239000011247 coating layer Substances 0.000 claims description 2
- GUYBGCBOZOALMT-UHFFFAOYSA-J dicalcium;fluoride;phosphate Chemical compound [F-].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O GUYBGCBOZOALMT-UHFFFAOYSA-J 0.000 claims description 2
- 239000012634 fragment Substances 0.000 claims description 2
- 239000004753 textile Substances 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 1
- 238000005520 cutting process Methods 0.000 claims 1
- 238000002513 implantation Methods 0.000 claims 1
- 239000004615 ingredient Substances 0.000 claims 1
- 239000010410 layer Substances 0.000 claims 1
- 229910052697 platinum Inorganic materials 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
- 230000000087 stabilizing effect Effects 0.000 claims 1
- 239000011521 glass Substances 0.000 description 19
- 210000002805 bone matrix Anatomy 0.000 description 9
- 239000011159 matrix material Substances 0.000 description 9
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- MCMNRKCIXSYSNV-UHFFFAOYSA-N Zirconium dioxide Chemical compound O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 description 4
- 239000000919 ceramic Substances 0.000 description 4
- 239000004744 fabric Substances 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- 230000002776 aggregation Effects 0.000 description 3
- 230000008468 bone growth Effects 0.000 description 3
- 230000001054 cortical effect Effects 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 238000011835 investigation Methods 0.000 description 3
- 230000002188 osteogenic effect Effects 0.000 description 3
- -1 For example Substances 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 2
- 238000005054 agglomeration Methods 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 230000008512 biological response Effects 0.000 description 2
- 210000002449 bone cell Anatomy 0.000 description 2
- 230000010072 bone remodeling Effects 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 239000000395 magnesium oxide Substances 0.000 description 2
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 210000000963 osteoblast Anatomy 0.000 description 2
- 210000005009 osteogenic cell Anatomy 0.000 description 2
- 239000011236 particulate material Substances 0.000 description 2
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000010936 titanium Substances 0.000 description 2
- 229910052719 titanium Inorganic materials 0.000 description 2
- 210000002268 wool Anatomy 0.000 description 2
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 229910019714 Nb2O3 Inorganic materials 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 208000006735 Periostitis Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 238000004125 X-ray microanalysis Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 239000005313 bioactive glass Substances 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- HPNSNYBUADCFDR-UHFFFAOYSA-N chromafenozide Chemical compound CC1=CC(C)=CC(C(=O)N(NC(=O)C=2C(=C3CCCOC3=CC=2)C)C(C)(C)C)=C1 HPNSNYBUADCFDR-UHFFFAOYSA-N 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 239000002657 fibrous material Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000003365 glass fiber Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000007373 indentation Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 239000006060 molten glass Substances 0.000 description 1
- 230000003448 neutrophilic effect Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000002997 osteoclast Anatomy 0.000 description 1
- 210000003460 periosteum Anatomy 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000011044 quartzite Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000004626 scanning electron microscopy Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229910001948 sodium oxide Inorganic materials 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 1
- 210000002303 tibia Anatomy 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/02—Inorganic materials
- A61L27/12—Phosphorus-containing materials, e.g. apatite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/30—Inorganic materials
- A61L27/32—Phosphorus-containing materials, e.g. apatite
-
- C—CHEMISTRY; METALLURGY
- C03—GLASS; MINERAL OR SLAG WOOL
- C03C—CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
- C03C3/00—Glass compositions
- C03C3/04—Glass compositions containing silica
- C03C3/076—Glass compositions containing silica with 40% to 90% silica, by weight
- C03C3/097—Glass compositions containing silica with 40% to 90% silica, by weight containing phosphorus, niobium or tantalum
-
- C—CHEMISTRY; METALLURGY
- C03—GLASS; MINERAL OR SLAG WOOL
- C03C—CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
- C03C4/00—Compositions for glass with special properties
- C03C4/0007—Compositions for glass with special properties for biologically-compatible glass
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/28—Bones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00005—The prosthesis being constructed from a particular material
- A61F2310/00179—Ceramics or ceramic-like structures
- A61F2310/00293—Ceramics or ceramic-like structures containing a phosphorus-containing compound, e.g. apatite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00389—The prosthesis being coated or covered with a particular material
- A61F2310/00592—Coating or prosthesis-covering structure made of ceramics or of ceramic-like compounds
- A61F2310/00796—Coating or prosthesis-covering structure made of a phosphorus-containing compound, e.g. hydroxy(l)apatite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Animal Behavior & Ethology (AREA)
- Inorganic Chemistry (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Geochemistry & Mineralogy (AREA)
- Materials Engineering (AREA)
- Ceramic Engineering (AREA)
- Molecular Biology (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT67096A IT1240938B (it) | 1990-02-08 | 1990-02-08 | Composizione vetrosa bioattiva per impianti ossei e prodotti ottenuti con tale composizione o che la comprendono |
IT67096A/90 | 1990-02-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH05502603A true JPH05502603A (ja) | 1993-05-13 |
Family
ID=11299541
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP3503103A Pending JPH05502603A (ja) | 1990-02-08 | 1991-02-04 | 骨インプラント用生物活性ガラス状組成物、それから造られたフィラメント及び方法 |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0514401A1 (pt) |
JP (1) | JPH05502603A (pt) |
KR (1) | KR950008173B1 (pt) |
AU (1) | AU639981B2 (pt) |
BR (1) | BR9106030A (pt) |
CA (1) | CA2075281A1 (pt) |
FI (1) | FI923561A (pt) |
HU (1) | HUT61899A (pt) |
IT (1) | IT1240938B (pt) |
WO (1) | WO1991012032A1 (pt) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2682968B1 (fr) * | 1991-10-28 | 1994-08-26 | Icmc | Procede de realisation d'un implant osseux, dispositif permettant de mettre en óoeuvre le procede et implant ainsi realise. |
WO1993017976A1 (en) * | 1992-03-09 | 1993-09-16 | Turku Implant Team Oy | Bioactive glass as a bone substitute |
US6121172A (en) * | 1993-11-15 | 2000-09-19 | The Trustees Of The University Of Pennsylvania | Composite materials using bone bioactive glass and ceramic fibers |
US5468544A (en) * | 1993-11-15 | 1995-11-21 | The Trustees Of The University Of Pennsylvania | Composite materials using bone bioactive glass and ceramic fibers |
FI101129B (sv) * | 1995-01-13 | 1998-04-30 | Vivoxid Oy | Nya bioaktiva glas och deras användning |
FI110063B (fi) | 1998-12-11 | 2002-11-29 | Antti Yli-Urpo | Uusi bioaktiivinen tuote ja sen käyttö |
FI117963B (fi) | 2001-04-26 | 2007-05-15 | Eija Marjut Pirhonen | Luuta korvaavat materiaalit |
EP2029184B1 (en) | 2006-05-26 | 2011-02-23 | Baxter International Inc. | Injectable fibrin composition for bone augmentation |
ATE452863T1 (de) * | 2006-09-20 | 2010-01-15 | Inion Oy | Bioaktive glaszusammensetzungen |
WO2008131154A2 (en) | 2007-04-23 | 2008-10-30 | Baxter International Inc. | Fibrin compositions containing strontium compounds |
US10751367B2 (en) | 2016-05-27 | 2020-08-25 | Corning Incorporated | Bioactive glass microspheres |
US20170342383A1 (en) | 2016-05-27 | 2017-11-30 | Corning Incorporated | Lithium disilicate glass-ceramic compositions and methods thereof |
WO2019108556A1 (en) | 2017-11-28 | 2019-06-06 | Corning Incorporated | Bioactive glass compositions and dentin hypersensitivity remediation |
EP3717426A1 (en) | 2017-11-28 | 2020-10-07 | Corning Incorporated | Chemically strengthened bioactive glass-ceramics |
WO2019108558A1 (en) | 2017-11-28 | 2019-06-06 | Corning Incorporated | High liquidus viscosity bioactive glass |
WO2019108557A1 (en) | 2017-11-28 | 2019-06-06 | Corning Incorporated | Bioactive borate glass and methods thereof |
EP3972941A1 (en) * | 2019-05-22 | 2022-03-30 | Corning Incorporated | Bioactive glass compositions |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1477899A (en) * | 1973-09-17 | 1977-06-29 | Leitz Ernst Gmbh | Manufacture of therapeutically useful composite materials |
JPS573739A (en) * | 1980-06-11 | 1982-01-09 | Nippon Kogaku Kk <Nikon> | Bioactive glass and glass ceramic |
JPS58118746A (ja) * | 1982-01-07 | 1983-07-14 | 株式会社ニコン | 歯科用インプラント及びその製造方法 |
CA1229354A (en) * | 1984-03-01 | 1987-11-17 | David C. Greenspan | Biologically active glass compositions for bonding to alloys |
JPS60186455A (ja) * | 1984-03-06 | 1985-09-21 | 株式会社ニコン | アパタイトコンポジツトセラミクス |
US4960733A (en) * | 1987-02-28 | 1990-10-02 | Hoya Corporation | Inorganic biomaterial and process for producing the same |
JPH02149447A (ja) * | 1988-12-01 | 1990-06-08 | Nippon Electric Glass Co Ltd | 歯科用結晶化ガラス |
-
1990
- 1990-02-08 IT IT67096A patent/IT1240938B/it active IP Right Grant
-
1991
- 1991-02-04 HU HU9202578A patent/HUT61899A/hu unknown
- 1991-02-04 BR BR919106030A patent/BR9106030A/pt not_active Application Discontinuation
- 1991-02-04 EP EP91902954A patent/EP0514401A1/en not_active Withdrawn
- 1991-02-04 JP JP3503103A patent/JPH05502603A/ja active Pending
- 1991-02-04 WO PCT/EP1991/000201 patent/WO1991012032A1/en not_active Application Discontinuation
- 1991-02-04 CA CA002075281A patent/CA2075281A1/en not_active Abandoned
- 1991-02-04 AU AU71491/91A patent/AU639981B2/en not_active Ceased
- 1991-02-04 KR KR1019920701897A patent/KR950008173B1/ko active IP Right Grant
-
1992
- 1992-08-07 FI FI923561A patent/FI923561A/fi not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU639981B2 (en) | 1993-08-12 |
EP0514401A1 (en) | 1992-11-25 |
CA2075281A1 (en) | 1991-08-09 |
FI923561A0 (fi) | 1992-08-07 |
IT9067096A1 (it) | 1991-08-08 |
IT9067096A0 (it) | 1990-02-08 |
BR9106030A (pt) | 1993-03-02 |
HUT61899A (en) | 1993-03-29 |
FI923561A (fi) | 1992-08-07 |
KR950008173B1 (ko) | 1995-07-26 |
AU7149191A (en) | 1991-09-03 |
IT1240938B (it) | 1993-12-27 |
WO1991012032A1 (en) | 1991-08-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH05502603A (ja) | 骨インプラント用生物活性ガラス状組成物、それから造られたフィラメント及び方法 | |
Baino | Bioactive glasses–when glass science and technology meet regenerative medicine | |
Xu et al. | Calcium phosphate cement containing resorbable fibers for short-term reinforcement and macroporosity | |
ES2367972T3 (es) | Biovidrio poroso y procedimiento de preparación. | |
DE60018600T2 (de) | Bioaktiver, abbaubarer verbundwerkstoff | |
RU2665361C2 (ru) | Композиции и их применение в регенерации костей | |
Müller-Mai et al. | Incorporation and degradation of hydroxyapatite implants of different surface roughness and surface structure in bone | |
RU2591087C2 (ru) | Материал заменителя кости | |
Dimitriadis et al. | Development of novel bioactive glass-ceramics in the Na2O/K2O-CaO-MgO-SiO2-P2O5-CaF2 system | |
Burnie et al. | Controlled release glasses (CRG) for biomedical uses | |
Hafezi et al. | Histological analysis of bone repair in rat femur via nanostructured merwinite granules | |
KR102230625B1 (ko) | 골 대체 물질 | |
US9199006B2 (en) | Combination products including bioactive glass and collagen and kits including the same | |
Zebon et al. | Efficacy of nano composite porous 3D scaffold of crab shell and Al-Kharit histological and radiological for bone repair in vivo | |
Baino et al. | Bioactive glass and glass–ceramic foam scaffolds for bone tissue restoration | |
Dorozhkin | Calcium orthophosphate-based bioceramics and its clinical applications | |
JP2003154001A (ja) | セリシン含有複合体およびその製造方法 | |
Guizzardi et al. | Low-temperature heat-deproteinated compact bone to heal large bone defects | |
Giavaresi et al. | Poly (2-hydroxyethyl methacrylate) biomimetic coating to improve osseointegration of a PMMA/HA/glass composite implant: in vivo mechanical and histomorphometric assessments | |
AU2014388329A1 (en) | Bioactive glass and collagen combination products and kits | |
de Pablos Martín et al. | Crystallization of Glasses and Its Impact on Bioactivity and Other Properties | |
RU2105529C1 (ru) | Хирургическое устройство и керамический биоактивный материал для остеосинтеза | |
Fernandes et al. | Characterization and biological performance of marine sponge collagen | |
DE10338634A1 (de) | Anorganisches resorbierbares Knochenersatzmaterial mit variabler mechanischer Festigkeit und Formkörper aus diesem Material | |
Lee et al. | A histological evaluation of novel cyanoacrylate-based β-TCP composite in rat calvarial defects |